| | | | | |
PRLD Prelude Therapeutics Incorporated | €4.8122 | +4.38 % | €348.55M | €401.34K | |
| €18.8919 | +1.63 % | €348.41M | €64.95K | |
ALTI AlTi Global, Inc. Class A Common Stock | €3.5314 | +0.12 % | €348.37M | €73.66K | |
HELP Cybin Inc. Common Stock | €9.7129 | +11.08 % | €348.12M | €1.69M | |
STRO Sutro Biopharma, Inc. | €16.9290 | -22.00 % | €346.79M | €363.60K | |
NPAC New Providence Acquisition Corp. III Class A Ordinary Shares | €9.0395 | +0.06 % | €346.66M | €22.57K | |
CCAP Crescent Capital BDC, Inc. Common stock | €9.6886 | -2.27 % | €346.44M | €104.31K | |
SWMR Swarmer, Inc Common Stock | €34.6250 | +1.23 % | €346.40M | €106.29K | |
| €5.8738 | -1.63 % | €345.99M | €184.14K | |
LSAK Lesaka Technologies, Inc. Common Stock | €4.1501 | -0.85 % | €345.73M | €25.49K | |
CCIX Churchill Capital Corp IX Ordinary Shares | €9.4286 | +0.00 % | €345.67M | €68.87K | |
BTQ BTQ Technologies Corp. Common Stock | €3.7662 | -1.90 % | €345.33M | €874.17K | |
FNLC First Bancorp, Inc. (ME) | €30.7634 | +0.22 % | €345.12M | €7.36K | |
SDHY PGIM Short Duration High Yield Opportunities Fund | €14.0615 | -0.70 % | €344.67M | €17.21K | |
LRMR Larimar Therapeutics, Inc. Common Stock | €3.7307 | -0.12 % | €344.34M | €290.53K | |
